|1.||Tufekcioglu, Omac: 1 article (01/2012)|
|2.||Aksu, Tolga: 1 article (01/2012)|
|3.||Colak, Ayse: 1 article (01/2012)|
|4.||Kajiura, Hideki: 1 article (11/2004)|
|5.||Kidachi, Yumi: 1 article (11/2004)|
|6.||Takata, Hiroki: 1 article (11/2004)|
|7.||Yamaguchi, Hideaki: 1 article (11/2004)|
|8.||Ryoyama, Kazuo: 1 article (11/2004)|
03/01/1998 - "13C-NMR data indicates that the main component in the active polysaccharide is the complex of alpha-1,6- and alpha-1,4-glucan, which had already been shown to have anti-tumor activity against Sarcoma 180. "
11/01/2004 - "Anti-tumor activity of an enzymatically synthesized alpha-1,6 branched alpha-1,4-glucan, glycogen."
|2.||Glycogen Storage Disease Type IV (Andersen's Disease)
08/01/1966 - "Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis."
01/01/2012 - "Glycogen storage disease type IV (GSD IV) is an autosomal recessive disorder due to the deficiency of α 1,4-glucan branching enzyme, resulting in an accumulation of amylopectin-like polysaccharide in various systems. "
|1.||1,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)